Shanghai Haohai Biological Technology Co., Ltd. (688366.SS)
CNY 61.2
(2.02%)
CNY 61.2
(2.02%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 712.95 Million CNY | 28.84% |
| 2022 | 444.04 Million CNY | -15.42% |
| 2021 | 548.25 Million CNY | 39.1% |
| 2020 | 394.8 Million CNY | -28.91% |
| 2019 | 554.31 Million CNY | -9.79% |
| 2018 | 600.47 Million CNY | 15.95% |
| 2017 | 533.08 Million CNY | 31.64% |
| 2016 | 400.87 Million CNY | 40.17% |
| 2015 | 286.72 Million CNY | 21.7% |
| 2014 | 235.95 Million CNY | 52.28% |
| 2013 | 154.71 Million CNY | 11.54% |
| 2012 | 147.04 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 183.49 Million CNY | 21.74% |
| 2024 Q3 | 125.62 Million CNY | -37.87% |
| 2024 Q1 | 117.24 Million CNY | -2.23% |
| 2023 FY | - CNY | 28.84% |
| 2023 Q4 | 137.57 Million CNY | -0.97% |
| 2023 Q3 | 138.92 Million CNY | -14.56% |
| 2023 Q2 | 162.6 Million CNY | 20.04% |
| 2023 Q1 | 135.45 Million CNY | 633.65% |
| 2022 FY | - CNY | -15.42% |
| 2022 Q4 | 18.46 Million CNY | -85.97% |
| 2022 Q3 | 131.58 Million CNY | 285.76% |
| 2022 Q2 | 34.11 Million CNY | -63.3% |
| 2022 Q1 | 92.94 Million CNY | 273.14% |
| 2021 Q3 | 85.17 Million CNY | -42.87% |
| 2021 Q4 | 24.9 Million CNY | -70.76% |
| 2021 FY | - CNY | 39.1% |
| 2021 Q2 | 149.09 Million CNY | 40.06% |
| 2021 Q1 | 106.45 Million CNY | -8.42% |
| 2020 Q1 | -48.8 Million CNY | -188.83% |
| 2020 Q4 | 116.23 Million CNY | 23.51% |
| 2020 Q3 | 94.11 Million CNY | 166.32% |
| 2020 Q2 | 35.33 Million CNY | 172.4% |
| 2020 FY | - CNY | -28.91% |
| 2019 Q4 | 54.94 Million CNY | -39.65% |
| 2019 FY | - CNY | -9.79% |
| 2019 Q1 | 94.09 Million CNY | -14.27% |
| 2019 Q3 | 91.03 Million CNY | -39.49% |
| 2019 Q2 | 150.45 Million CNY | 59.89% |
| 2018 FY | - CNY | 15.95% |
| 2018 Q4 | 109.76 Million CNY | 0.0% |
| 2018 Q3 | 109.76 Million CNY | -8.65% |
| 2018 Q1 | 120.15 Million CNY | -0.55% |
| 2018 Q2 | 120.15 Million CNY | 0.0% |
| 2017 FY | - CNY | 31.64% |
| 2017 Q4 | 120.81 Million CNY | 0.0% |
| 2017 Q3 | 120.81 Million CNY | 22.29% |
| 2017 Q2 | 98.79 Million CNY | 0.0% |
| 2017 Q1 | 98.79 Million CNY | 17.42% |
| 2016 Q2 | 75.58 Million CNY | 0.0% |
| 2016 Q4 | 84.13 Million CNY | 0.0% |
| 2016 Q3 | 84.13 Million CNY | 11.31% |
| 2016 Q1 | 75.58 Million CNY | 39.53% |
| 2016 FY | - CNY | 40.17% |
| 2015 FY | - CNY | 21.7% |
| 2015 Q3 | 54.17 Million CNY | -26.57% |
| 2015 Q2 | 73.77 Million CNY | 0.0% |
| 2015 Q1 | 73.77 Million CNY | 27.9% |
| 2015 Q4 | 54.17 Million CNY | 0.0% |
| 2014 Q1 | 47.08 Million CNY | 26.86% |
| 2014 Q4 | 57.67 Million CNY | 0.0% |
| 2014 Q2 | 47.08 Million CNY | 0.0% |
| 2014 FY | - CNY | 52.28% |
| 2014 Q3 | 57.67 Million CNY | 22.51% |
| 2013 Q2 | 40.24 Million CNY | 0.0% |
| 2013 Q3 | 37.11 Million CNY | -7.78% |
| 2013 Q4 | 37.11 Million CNY | 0.0% |
| 2013 FY | - CNY | 11.54% |
| 2013 Q1 | 40.24 Million CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |